Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Latest filing published 23 Jun 2026 for Indivior Pharmaceuticals, Inc.. Read the official filing
Filing timeline
BuySaleJoseph Ciaffoni
Insider track record
Disclosed buys
0
Disclosed sells
8
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Joseph Ciaffoni: trading record in brief
Joseph Ciaffoni, listed as chief executive, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Collegium Pharmaceutical, Inc and Indivior Pharmaceuticals, Inc. The record holds 25 filings, for trades running from 1 June 2021 to 22 June 2026.
The open-market record consists of 8 sales worth €2.4M, with no purchase. The rest of the record consists of 10 share grants and 7 option exercises.
Most recently, on 23 June 2026, the filings show an option exercise in Indivior Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Joseph Ciaffoni
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations25 total
1,266,903 sharesCommon StockSEC:0001443841-26-000007:0
612,549 sharesCommon StockSEC:0001443841-26-000007:1
79,976 shares0Common StockSEC:0001443841-26-000004:0
119,000 shares0Common StockSEC:0001062993-24-003166:0
4,357 shares@ US$21.341.8% of flowCommon StockSEC:0001062993-23-023100:0
27,798 shares@ US$21.3411.9% of flowCommon StockSEC:0001062993-23-022977:0
31,272 shares@ US$22.088714.0% of flowCommon StockSEC:0001062993-23-012809:0
31,271 shares@ US$21.902313.9% of flowCommon StockSEC:0001062993-23-012623:0
117,500 shares0Common StockSEC:0001062993-23-003475:0
110 shares@ US$23.000.1% of flowCommon StockSEC:0001062993-22-024500:0
147 shares@ US$23.000.1% of flowCommon StockSEC:0001062993-22-024500:1
1,804 shares@ US$23.650.9% of flowCommon StockSEC:0001062993-22-024500:2
400 shares@ US$24.190.2% of flowCommon StockSEC:0001062993-22-024500:3
1,134 shares@ US$23.010.5% of flowCommon StockSEC:0001062993-22-024355:0
76,653 shares@ US$15.9025.5% of flowCommon StockSEC:0001062993-22-023357:0
43 shares@ US$15.900.0% of flowCommon StockSEC:0001062993-22-022995:0
65 shares@ US$15.900.0% of flowCommon StockSEC:0001062993-22-022779:0
1,989 shares@ US$15.900.7% of flowCommon StockSEC:0001062993-22-022644:0
1,394 shares@ US$18.160.5% of flowCommon StockSEC:0001062993-22-016068:0
65,083 shares@ US$18.3724.0% of flowCommon StockSEC:0001062993-22-006644:0
125,000 shares0Common StockSEC:0001062993-22-004320:0
1,090 shares@ US$18.680.4% of flowCommon StockSEC:0001879789-22-000001:0
1,386 shares@ US$19.030.5% of flowCommon StockSEC:0001192482-21-000661:0
1,394 shares@ US$23.990.6% of flowCommon StockSEC:0001192482-21-000623:0
4,672 shares@ US$22.902.0% of flowCommon StockSEC:0001192482-21-000479:0
25 of 25 declarations
